Using TCGA somatic mutation data, astrocytoma plus oligodendroglioma (defined as low-grade glioma (LGG)) exhibited the most frequent somatic mutations in IDH1 (92%), followed by TP53 (49%), ATRX (46%), and CIC (28%). This evidence concerns the gene ATRX and astrocytoma (excluding glioblastoma).